In contrast, short-acting formulations such as exenatide and the older-generation agent lixisenatide are now prescribed far less frequently, and several formulations have been withdrawn from the market in certain countries, largely due to limited clinical uptake, the availability of more effective long-acting alternatives, and commercial considerations rather than confirmed safety concerns
Retrieved 7 January 2019
Risks and Safety Considerations You Should Be Aware Of Using unlicensed retatrutide carries serious risks including unknown purity, infection from non-sterile technique, unmonitored adverse effects such as nausea and increased heart rate, and potential drug interactions
Athletic Performance And Recovery Athletes and dedicated exercisers stress both their energy systems and their antioxidant systems
Potential side effects Do not take these medications together which can cause hypoglycemia (low blood sugar levels)
Click here to learn more and see if Zepbound is right for you: Explore content categories